Compare +50 FDA PMA Providers

PMA work is usually won or lost in execution details: protocol strategy, evidence consistency, biostatistics discipline, and response quality under time pressure. This page gives you a practical shortlist framework so you can compare provider fit quickly and avoid buying a generic "full service" package that does not match your stage.

How to Use This Directory

Use this directory as a structured comparison approach, not a quote funnel. Start with three dimensions: scope fit, risk fit, and operating fit. Scope fit means the provider has delivered the exact PMA workstream you need now. Risk fit means they have a credible method for managing your biggest uncertainty, such as enrollment slippage, primary endpoint sensitivity, device accountability, or benefit-risk narrative pressure. Operating fit means their process integrates with your team and timeline, including document control expectations and weekly decision cadence.

If your program is pre-IDE, prioritize providers with protocol and endpoint design depth. If your study is active, prioritize data quality operations and deviation response capability. If your data lock is near, prioritize statistical interpretation and PMA narrative integration. If your first PMA deficiency round has already occurred, prioritize teams with fast remediation systems and strong cross-functional writing discipline.

High-Intent PMA Search Themes You Should Map

Commercial and informational search behavior around PMA services usually clusters around terms such as "FDA PMA consultant," "PMA submission support," "PMA clinical trial design consultant," "PMA biostatistics service," "PMA deficiency response support," and "PMA supplement strategy." Whether you source providers via search, referrals, or conference networks, your screening criteria should align to these practical buyer intents: timeline confidence, response quality, and total program cost control.

To convert those intents into measurable comparisons, define a one-page scorecard before outreach. Require each provider to answer the same scenario questions. Example: "How would you adjust our analysis plan if enrollment ends 15% below target?" and "What is your 30-day turnaround method for an FDA deficiency package?" This removes marketing noise and keeps your comparison grounded in execution capability.

Provider Scoring Tool

Decision Criteria That Actually Predict PMA Outcomes

1) Evidence architecture: can the team align clinical, non-clinical, manufacturing, and labeling arguments into one coherent benefit-risk storyline? 2) Statistical resilience: can they preemptively address missing data, protocol deviations, and sensitivity checks? 3) Module-level writing quality: can they produce concise, internally consistent modules with clear references and minimal contradiction risk? 4) Review cycle discipline: can they run high-frequency review loops with version control, owner accountability, and dated change logs?

In PMA, inconsistent writing is not just a style issue; it is a review risk. If your device description says one thing while your protocol assumptions imply another, credibility drops fast. Strong providers run contradiction checks before every formal package. Ask directly how they perform cross-module consistency QA and what their defect taxonomy looks like.

Internal Links and Next Steps

If you are building your planning model right now, start with these calculators:

• PMA Clinical Evidence Gap Calculator
• PMA Review Timeline Calculator
• PMA Budget Calculator

Teams coming from a 510(k)-first process can also use our 510(k) checklist guide and fees/timeline benchmark page to compare pathway economics before final regulatory strategy decisions.

Citations

[1] FDA: Premarket Approval (PMA)
[2] 21 CFR Part 814
[3] FDA: Device User Fee and Small Business Qualification